ALZINOVA AB
Patent Applications and Registrations
Patent applications and USPTO patent grants for ALZINOVA AB.The latest application filed is for "stable amyloid beta monomers and oligomers".
- ALZINOVA AB - Gothenburg N/A SE
- ALZINOVA AB - Goteborg SE
| Patent | Date |
|---|---|
| Stable amyloid beta monomers and oligomers Grant 10,138,281 - Hard , et al. Nov | 2018-11-27 |
| Method of immunization for reducing toxic damaged caused by oligomeric form of the amyloid-beta protein with stable amyloid beta monomers and oligomers Grant 10,023,622 - Hard , et al. July 17, 2 | 2018-07-17 |
| Stable Amyloid Beta Monomers And Oligomers App 20180030103 - HARD; Torleif ; et al. | 2018-02-01 |
| Stable Amyloid Beta Monomers And Oligomers App 20170355737 - HARD; Torleif ; et al. | 2017-12-14 |
| Stable amyloid beta monomers and oligomers Grant 9,688,734 - Hard , et al. June 27, 2 | 2017-06-27 |
| Anti Oligomer Antibodies And Uses Thereof App 20130344089 - Sjoblom-Hallen; Anna ; et al. | 2013-12-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 